Why this conversation matters
Stopping a GLP-1 medication without a plan is one of the more common, avoidable sources of frustration in treatment. Research on weight regain after discontinuation is consistent: stopping abruptly, without any transition strategy, tends to produce faster and more complete regain than a planned approach. Bringing this up directly with your prescriber — rather than just not refilling a prescription — gives you a real say in how that transition happens.
Reasons this conversation comes up
- Cost or insurance coverage changes
- Side effects that haven't resolved
- Reaching a personal goal weight and wanting to assess next steps
- General fatigue with ongoing injections or a desire to try life without the medication
Questions worth asking
- "If I stop, what should I realistically expect in terms of appetite and weight over the following months?"
- "Is there a tapering approach, or is this an all-or-nothing medication?" (Some prescribers use a reduced maintenance dose rather than a hard stop — see the discussion of dose reduction vs. full discontinuation in our history of GLP-1 medications guide.)
- "What should I change about my diet or exercise routine going into this transition?"
- "If I decide to restart later, what does that process look like?"
If cost is the driver
Say so directly — a prescriber who knows cost is the reason may have options you haven't considered: a different, less expensive drug in the same class, manufacturer savings programs, or a structured dose-reduction plan rather than a full stop. This is a different conversation than one driven by side effects or reaching a goal, and naming the real reason helps your prescriber actually help you.
The bottom line
Stopping treatment is a legitimate decision, but it's a decision worth making with your prescriber's input, not around it — especially given how directly research links planned tapering to better long-term outcomes than an abrupt stop.